NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025)
NovaBridge Biosciences (NBP) reported Cash from Financing Activities of $57.7 million for Q4 2025, up 1604.82% on a QoQ basis from -$3.8 million in Q3 2024.
NovaBridge Biosciences (NBP) has 4 years of Cash from Financing Activities data on file, last reported at $57.7 million in Q4 2025.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $57.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $53.9 million (down 86.67% YoY) and the FY2025 annual result came in at $57.7 million, up 1483.96% from the prior year.
- Cash from Financing Activities rose to $57.7 million in Q4 2025 per NBP's latest filing, from -$3.8 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $57.7 million in Q4 2025 and bottomed at -$3.8 million in Q3 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.73 Mn |
| Dec 31, 2025 | 57.73 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Dec 31, 2019 | 16.07 Mn |
| Dec 31, 2019 | 16.07 Mn |